Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Home Liver Transplantation Experimental treatment could help patients grow new livers

Experimental treatment could help patients grow new livers

by Rich Johnson
0 comments

(NewsNation) — For tens of thousands of people seeking a liver transplant, it could be a lifeline. It is possible to grow a new liver within your own body.

Biotechnology company LyGenesis For the first time, the researchers said they injected human patients with a cocktail containing donated liver cells. The goal is to turn the lymph nodes into a small but functioning liver.

Researchers began the first human trial in late March, injecting the treatment into 12 patients, all with end-stage liver disease (ESLD).

“If our research is successful and FDA-approved, our allogeneic cell therapy will allow us to treat dozens of ESLD patients with one donated liver, meeting current organ demands.” and could help tip the supply imbalance in favor of patients,” he said. Michael Hufford, co-founder and CEO of LyGenesis.

Approximately 4.5 million people develop liver disease and more than 50,000 die from liver disease each year. But nAround 10,000 people are on the waiting list. Not all donated livers are suitable for transplantation.

Regenesis says the new treatment requires only a few cells taken from the liver, meaning each donated organ can provide enough material to treat up to 75 people.

The human trials followed animal trials conducted over the past few years. In one study, mice injected with the compound grew enough liver tissue in their lymph nodes to take over the work of a diseased liver. In further research, the pigs grew new livers that were larger than the animals’ damaged livers.

The liver is unique among human organs in that it has the ability to heal itself. Damaged liver tissue sends signals to healthy tissue to regenerate itself.

news source

You may also like

About Us

Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.

About Us

Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.

Copyright ©️ 2024 Daily Transplant News | All rights reserved.